GetAttachmentThumbnail.png

SOLARIS PHARMA

About Our Company

A leading specialty dermatology company in Bridgewater Township, NJ

WHO WE ARE

About Us

Solaris Pharma Corporation is a leading specialty dermatology company committed to the identifying, developing and marketing of high-quality, generic and specialty pharmaceutical products. Solaris Pharma Corporation employs an experienced R&D and management team focused on right-first-time development while maintaining the highest quality standards. With a strong financial position and employee centric focus, the company strives to be a pacesetter in the niche dermatology market.

 

Solaris Pharma Corporation is dedicated to developing a broad portfolio of generic and specialty dermatological products to provide patients with alternative options for high quality, affordable, effective, generic and value-added products. We aim to achieve this based on sound science, while being cost-effective and time-efficient in product development, leading to rapid approvals by the Agency allowing for faster entry of our products into the market.

 

Dermatology products are challenging to develop and manufacture with complexities arising from formulation & process development, stability and scale up. In addition, a majority of the dermatology products require experimentally challenging in-vitro or in some instances expensive clinical studies, which act as a barrier to entry for many companies. Such products offer a niche market opportunity for Solaris Pharma Corporation.

solaris_347x103_edited.png
shutterstock_691548586.jpg
Pic 1.jpeg

Solaris Pharma Corporation is currently developing several topical & transdermal products, which are in different stages of development. The company has a dedicated team of committed and well-trained scientists along with experienced program managers and regulatory personnel who provide a robust product development process. The entire end-to-end product development process has been validated through multiple product approvals. A robust commercial infrastructure is in place to market our approved products. The commercial team has reinforced our success with product approvals in successfully launching our first product under the Solaris label into the market.

 

The topical dosage forms that are being developed at our facility include: Ointments, Gels, Creams, Lotions, Solutions, Sprays, and Foams.

 

These products target several indications such as: Pain, Acne, Psoriasis, Atopic Dermatitis, Fungal infections, and Rosacea

solaris_347x103_edited.png